Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury

Circulation

Volumn 101, Issue 9, 2000, Pages 1019-1026

  Yang, Zequan ^a   Zingarelli, Basilia ^a   Szabó, Csaba ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b INOTEK CORPORATION   (United States)

Author keywords

Cell adhesion molecules; Interleukins; Nitric oxide; Reperfusion

Indexed keywords

CELL ADHESION MOLECULE; INTERLEUKIN 10; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; GENE DELETION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TUMOR SUPPRESSOR GENE;

EID: 0034048281     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.9.1019     Document Type: Article

References (41)

1. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, Sato N, Arakawa N, Suzuki T, Aoki H, Suzuki T, Hiramori K. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res. 1997;17: 145-150.
2. Seghaye M, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, Lecronier G, Mokhfi E, Planche C. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996;111:545-553.
3. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Mori A. Interleukin-10 concentration in children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:1127-1128.
4. Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL, Goldman M, Vincent JL, LeClerc JL. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996;111:469-477.
5. Perretti M, Szabo C, Thiemermann C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol. 1995;116:2251-2257.
6. Standiford TJ, Stricter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol. 1995;155:2222-2229.
7. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, Grünig G, Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995;96:2339-2347.
8. + TH1-like responses. J Clin Invest. 1996;98: 1010-1020.
9. -/- mice: an overview. J Leukoc Biol. 1997;61:389-396.
10. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
11. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol. 1998;275:H1375-H1387.
12. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 1998;98:441-449.
13. Zingarelli B, Salzman AL, Szabó C. Genetic disruption of poly(ADP ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. Circ Res. 1998;83:85-94.
14. Haskó G, Virág L, Egnaczyk G, Salzman AL, Szabó C. The crucial role of Interleukin-10 in the suppression of the immune response in mice exposed to staphylococcal enterotoxin B. Eur J Immunol. 1998;28: 1417-1425.
15. Kukielka GL, Hawkins HK, Michael L, Manning AM, Youker K, Lane CL, Entman ML, Smith CW, Anderson DC. Regulation of intercellular adhesion molecule-1 (ICAM-1 ) in ischemic and reperfused canine myocardium. J Clin Invest. 1993:92:1504-1516.
16. Jerome SH, Doré M, Paulson JC, Smith CW, Korthuis RJ. P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. Am J Physiol. 1994;266:H1316-H1321.
17. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation. 1995;59:565-572.
18. Zhai QH, Futrell N, Chen FJ. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. J Neural Sci. 1997;152:119-124.
19. Le Moine O, Louis H, Stordeur P, Collet JM, Goldman M, Deviere J. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology. 1997;113: 1701-1706.
20. Hayward R, Nossuli TO, Scalia R, Lefer AM. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur J Pharmacol. 1997:334:157-163.
21. Hess PJ, Seeger JM, Huber TS, Welborn MB, Martin TD, Harward TR, Duschek S, Edwards PD, Solorzano CC, Copeland EM, Moldawer LL. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J Vasc Surg. 1997;26:113-118.
22. Engles RE, Huber TS, Zander DS, Hess PJ, Welborn MB, Moldawer LL, Seeger JM. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J Surg Res. 1997;69:425-428.
23. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett. 1998;251:189-192.
24. Raisanen-Sokolowski A, Glysing-Jensen T, Russell ME. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol. 1998;153:1491-500.
25. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C. Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils. Scand J Immunol. 1997;45:269-275.
26. Song S, Ling-Hu H, Roebuck KA, Rabbi MF, Donnelly RP, Finnegan A. Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood. 1997;89: 4461-4469.
27. Lindner H, Holler E, Gerbitz A, Johnson JP, Bornkamm GW, Eissner G. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: interleukin-10 protects against transendothelial migration. Transplantation. 1997;64:1370-1373.
28. Benyo Z, Kiss G, Szabo C, Csaki C, Kovach AG. Importance of basal nitric oxide synthesis in the regulation of myocardial blood flow. Cardiovasc Res. 1991;25:700-703.
29. Hasebe N, Shen YT, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 1993;88:2862-2871.
30. Egdell RM, Siminiak T, Sheridan DJ. Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion. Basic Res Cardiol. 1994;89:499-509.
31. Sato H, Zhao ZQ, Jordan JE, Todd JC, Riley RD, Taft CS, Mammon JW Jr, Li P, Ma X, Vinten-Johansen J. Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization. J Thorac Cardiovasc Surg. 1997;113:399-409.
32. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res. 1996; 32:743-751.
33. Liu P, Hock CE, Nagele R, Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol. 1997;272:H2327-H2336.
34. Chandrasekar B, Streitman JE, Colston JT, Freeman GL. Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim Biophys Acta. 1998;1406:91-106.
35. Szabó C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA. 1994;91:2472-2476.
36. Wildhirt SM, Suzuki H, Horstman D, Weismuller S, Dudek RR, Akiyama K, Reichart B. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction. Circulation. 1997;96: 1616-1623.
37. Parrino PE, Laubach VE, Gaughen JR Jr, Shockey KS, Wattsman TA, King RC, Tribble CG, Kron IL. Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow. Ann Thorac Surg. 1998;66:733-739.
38. Hask G, Szabó C. Modulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomie nervous system. Biochem Pharmacol. 1998;56:1079-1087.
39. Minami M, Driscoll EM, Simpson PJ, Hoff PT, Lucchesi BR. Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model. Pharmacology. 1995;50:24-33.
40. Hill RJ, Oleynek JJ, Magee W, Knight DR, Tracey WR. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J Mol Cell Cardiol. 1998;30:579-585.
41. Auchampach JA, Rizvi A, Qiu Y, Tang XL, Maldonado C, Teschner S, Bolli R. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res. 1997;80:800-809.